Longevity Patent Family

SGLT2 ANTAGONISTS TO DELAY OVARIAN AGING

Source-linked patent metadata for SGLT2 ANTAGONISTS TO DELAY OVARIAN AGING, including priority, record stage and longevity-topic connections.

Patent-family snapshot

Application publication visible

Family grouping brings related publications for the same invention together, instead of counting every national filing as a separate technology.

Representative publication
WO2026035622A1
Earliest priority
August 8, 2024
Latest publication
February 12, 2026
Family publications
1
Patent offices
1
Patent-to-Evidence Translation Map

What is happening in the same scientific field?

These connections share a longevity topic with this patent record. They do not prove that the listed evidence, trials, funders, or universities validate, finance, own, or support this invention.

Organizations

Organizations named in this family

OKLAHOMA MED RES FOUND [US]ApplicantOKLAHOMA MEDICAL RESEARCH FOUNDATIONApplicant
Longevity context

Topics connected by metadata

Ovarian ageing88% metadata match
Knowledge connections

What this family cites

Earlier patent references
0
Scientific and other non-patent references
0
Priority dates represented
1

References show which earlier documents the patent record points to. They do not validate the invention or prove that cited research supports its claims.

Technical classification

How the patent office classifies this invention

No patent classification is available in the retained record.

Verify in the original patent source →